首页> 外文期刊>European Journal of Cancer Supplements >54LBA High coexpression of both the insulin-like growth factor receptor-1 (IGF-1R) and epidermal growth factor receptor (EGFR) correlates with a poor patient prognosis in resected non-small cell lung cancer (NSCLC)

【24h】

54LBA High coexpression of both the insulin-like growth factor receptor-1 (IGF-1R) and epidermal growth factor receptor (EGFR) correlates with a poor patient prognosis in resected non-small cell lung cancer (NSCLC)

机译：54LBA胰岛素样生长因子受体1（IGF-1R）和表皮生长因子受体（EGFR）的高共表达与切除的非小细胞肺癌（NSCLC）患者预后差有关

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第3期|共1页
作者
K.Gately; L.Forde; S.Cuffe; E.Kay; K.OByrne;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. [J] . Ludovini V, Bellezza G, Pistola L Annals of oncology: official journal of the European Society for Medical Oncology . 2009,第5期

机译：胰岛素样生长因子受体1（IGFR-1）和表皮生长因子受体（EGFR）的高共表达与切除的非小细胞肺癌患者的无病生存期较短有关。
2. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients [J] . V. Ludovini1* G. Bellezza2 L. Pistola1 F. Bianconi3 L. Di Carlo4 A. Sidoni2 A. Semeraro4 R. Del Sordo2 F. R. Tofanetti1 M. G. Mameli2 G. Daddi4 A. Cavaliere2 M. Tonato5 and L. Crinò1 Annals of Oncology . 2009,第5期

机译：胰岛素样生长因子受体-1（IGFR-1）和表皮生长因子受体（EGFR）的高共表达与切除的非小细胞肺癌患者较短的无病生存期相关
3. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations [J] . Yeo Chang Dong, Park Ki Hoon, Park Chan Kwon, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2015,第3期

机译：胰岛素样生长因子1受体（IGF-1R）的表达预测在具有激活的EGFR突变的非小细胞肺癌患者中对表皮生长因子受体（EGFR）酪氨酸激酶抑制剂的不良反应
4. Targeting of Epidermal Growth Factor Receptor (EGFR)-positive pancreatic cancer cell lines with cetuximab-conjugated near-infrared silver sulphide quantum dots [C] . Peter L. Labib, Elnaz Yaghini, Mahshid Hashemkhani, International Photodynamic Association World Congress;Society of Photo-Optical Instrumentation Engineers;International Photodynamic Association . 2019

机译：西妥昔单抗缀合的近红外硫化银量子点靶向表皮生长因子受体（EGFR）阳性胰腺癌细胞系
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Dual blockade of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine erlotinib and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727) [O] . Philip A. Philip, Bryan Goldman, Ramesh K. Ramanathan, -1

机译：转移性胰腺癌中表皮生长因子受体（EGFR）和胰岛素样生长因子受体1（IGF-1R）信号的双重阻断：吉西他滨厄洛替尼和西妥木单抗的Ib期和随机II期试验与吉西他滨加厄洛替尼（SWOG S0727）
7. Real-World Analysis of Clinical Characters, Prognosis, And Recurrence Pattern: A Retrospective Multicenter Study of 429 Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) [O] . K. Xu, N. BI, H. Ge, 2020

机译：真实世界分析临床特征，预后和复发模式：429例表皮生长因子受体（EGFR）突变体局部晚期非小细胞肺癌的回顾性多中心研究（LA-NSCLC）

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号